The latest medical technique to treat fibroid tumors, exablation, "offers significant advantages over existing treatments for uterine fibroids," says the FDA. The incision-free fibroid tumor treatment that destroys tumors with high-energy sound waves, or ultrasound, is now available from SightLine Health in Atlanta.

In the U.S. since 2004, FDA approved exablation combines magnetic resonance imaging with ultrasound technology. Using magnetic images to view fibroids from many angles inside the body, a gynecologist trained in exablation directs high intensity sound waves at fibroid tumors to shrink and destroy them. There is no incision, general anesthesia or hospitalization associated with the procedure.

According to the National Institutes of Health, at least 25 percent of women in the U.S. between the ages of 25 and 50 suffer from uterine fibroids. In African-American women, the percentage is almost double.

Fibroids are abnormal growths within the muscles of the uterus. Although benign, fibroids often cause symptoms such as painful, heavy menstrual bleeding, constipation and lower back pain. They also can cause miscarriages or premature labor.

Headquartered in Houston, Texas, one of the country's leading medical communities, SightLine Health (www.sightlinehealth.com) brings patients access to emerging technology. It is one of the few U.S. companies offering uterine fibroid treatment with ExAblate technology, the only FDA-approved MR-guided focused ultrasound (MRgFUS) equipment. SightLine is affiliated with dedicated radiologists and gynecologists with decades of knowledge in women's health and MRI technology.

www.sightlinehealth.com
404-592-1389